MetabolicSEMAGLUTIDE
5MG
$65
Description
Semaglutide 5MG is a lower-dose formulation of the GLP-1 receptor agonist, ideal for initial research protocols or dose-titration studies. Semaglutide mimics the incretin hormone GLP-1 to regulate appetite, blood sugar, and metabolic function by binding to GLP-1 receptors in the pancreas, gut, and brain. Its modified structure with a fatty acid side chain enables albumin binding, extending its half-life to approximately 7 days. The 5MG formulation provides a flexible entry point for metabolic research.
Potential Benefits
Research Notes
Semaglutide is backed by the STEP and SELECT clinical trial programs published in the New England Journal of Medicine. The 5MG formulation provides the same well-researched compound in a lower concentration, suitable for dose-finding studies and initial research protocols where gradual dose escalation is preferred.
Usage Information
For research and educational purposes only. Consult with a qualified professional before use.
All peptides must be refrigerated upon receipt.
RESEARCH PURPOSES ONLY
This product is intended for research and educational purposes only. Not intended for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.